跳至主要内容
临床试验/CTRI/2024/10/075075
CTRI/2024/10/075075暂停不适用

Evaluation of Dermatological Safety of Test Product(DRDC/2024/038) by 24 Hours Patch Test under Complete Occlusion on Adult Healthy Human Participants with Sensitive Skin

Dabur India Limited1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2024年10月10日最近更新:

试验速览

阶段
不适用
状态
暂停
入组人数
24
试验地点
1
主要终点
Change in Skin Irritation Score-erythema & oedema

研究概览

简要总结

The below products would be tested as per the guideline IS4011 for dermal safety assessment.

  1. DRDC/2024/038

The product will be tested for skin irritation on 24 human volunteers.

Assessment would be done on day 0, day 2, with followup visit on day 8 for erythema and Oedema scoring.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Voluntary man or women (preferably equal number of males and females) between 18 and 65 years with sensitive skin
  • Fitzpatrick type III to V.
  • Having apparently healthy skin on test area
  • For whom the investigator considers that the compliance will be correct.
  • Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • Having signed a Consent Form.
  • Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study.
  • Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
  • Should be able to read and write (in English, Hindi or local language).
  • Having valid proof of identity and age.
  • Subject having not participated in another trial in the past one month.

排除标准

  • Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 4.Dermatological infection or pathology on the level of studied area 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Chronic illness which may influence the outcome of the study 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

结局指标

主要结局

Change in Skin Irritation Score-erythema & oedema

时间窗: Day 0, Day 2(24 hours post patch removal), Day 8 (1 week post patch removal)

次要结局

  • Not Applicable(Not Applicable)

研究者

申办方类型
Other [Ayurvedic and Natural Healthcare]
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验

Safety Test of Product(DRDC/2024/038) by Patch Test... | 临床试验